Pharma giants to inform risk of COVID vaccine-associated Enhanced Respiratory Disease: DCGI Ruchika Sharma25 Sept 2020 1:46 PM ISTDr Bhargava answered in view of the draft guidelines published by the Central Drugs Standard Control Organisation (CDSCO) for the development of a...
Mylan, CSIR join hands to identify advance COVID-19 therapies MD Bureau25 Sept 2020 11:30 AM ISTNew Delhi: The Council of Scientific and Industrial Research (CSIR), India's premier research organisation, and Mylan Laboratories Ltd on Wednesday...
DCGI nod to Bayer Aflibercept injection to treat diabetic macular edema Ruchika Sharma24 Sept 2020 1:30 PM IST"Intravitreal Aflibercept offers patients impacted by diabetic vision loss a new option to be proactive and stay ahead of the disease," Bayer Zydus...
BDR Pharma unveils prostate cancer drug enzalutamide at Rs 24480 per pack in India Ruchika Sharma22 Sept 2020 11:30 AM ISTThe 80 mg version is an attempt to reduce the pill burden as it is expected to increase the patient compliance, it added.
Serum Institute gets DCGI nod to restart Oxford Vaccine trial with certain conditions Ruchika Sharma17 Sept 2020 11:37 AM ISTDSMB, India, also has recommended to continue the study and enroll the remaining participants in the clinical trial as per protocol subject to certain...
HUL gets DCGI notice over misleading Immunity Boosting Hand Sanitizer ad to prevent COVID-19 Farhat Nasim15 Sept 2020 1:24 PM ISTNew Delhi: Taking into account the violation of the Drugs and Cosmetics Act, 1940, and Drugs and Cosmetics Rules, 1945; the Drug Controller General of...
AstraZeneca restarts COVID-19 vaccine trials in UK Ruchika Sharma14 Sept 2020 1:00 PM ISTIt added that safety reviewers had recommended to Britain's Medicines Health Regulatory Authority(MHRA) that it was safe to resume the British trials.
New Covid-19 drug Baladol gets DCGI nod for human trial MD Bureau12 Sept 2020 10:00 AM ISTNew Delhi: Amid the raging coronavirus pandemic, PNB Vesper Life Science Private Limited on Friday received approval from the Drug Controller General...
CDSCO commmitee nod to Cipla, Optimus phase 4 trials of COVID drug favipiravir Farhat Nasim11 Sept 2020 3:00 PM ISTNew Delhi: Drug major Cipla Ltd and Optimus Pharma have recently secured permission from the expert's panel of Central Drugs Standard Control...
Serum Institute halts COVID vaccine trials in India MD Bureau11 Sept 2020 10:00 AM ISTIn a statement, the Serum Institute of India said: "We are reviewing the situation and pausing India trials till AstraZeneca restarts the trials. We...
Suspension of Covishield trials in UK spells havoc for Astrazeneca and Serum Institute of India Ruchika Sharma10 Sept 2020 1:58 PM ISTNew Delhi: Owing to a suspected severe adverse reaction on a participant after being administered a booster dose of Covishield, the Drugs Controller...
DCGI green flag to Abbott heart failure, angina treatment drug Ivabradine Farhat Nasim3 Sept 2020 4:54 PM ISTAbbott plans to launch Ivabradine prolonged-release tablets in the Indian market in the coming weeks.
